Deutsche Bank AG Grows Stock Holdings in Indivior PLC (NASDAQ:INDV)

Deutsche Bank AG increased its holdings in shares of Indivior PLC (NASDAQ:INDV - Free Report) by 14.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 288,473 shares of the company's stock after acquiring an additional 35,953 shares during the period. Deutsche Bank AG owned approximately 0.21% of Indivior worth $3,586,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Mirae Asset Global Investments Co. Ltd. acquired a new stake in Indivior in the fourth quarter valued at $56,000. Stifel Financial Corp lifted its stake in shares of Indivior by 24.0% in the fourth quarter. Stifel Financial Corp now owns 12,675 shares of the company's stock valued at $158,000 after purchasing an additional 2,450 shares during the period. Rathbones Group PLC boosted its holdings in Indivior by 11.6% during the fourth quarter. Rathbones Group PLC now owns 14,284 shares of the company's stock worth $183,000 after buying an additional 1,483 shares in the last quarter. China Universal Asset Management Co. Ltd. purchased a new stake in Indivior during the fourth quarter worth about $359,000. Finally, Balyasny Asset Management L.P. grew its position in Indivior by 142.5% during the fourth quarter. Balyasny Asset Management L.P. now owns 36,381 shares of the company's stock worth $452,000 after buying an additional 21,379 shares during the period. Institutional investors and hedge funds own 60.33% of the company's stock.

Indivior Price Performance

Shares of NASDAQ INDV traded up $0.05 on Monday, hitting $11.26. The company's stock had a trading volume of 1,303,351 shares, compared to its average volume of 1,022,970. The stock has a 50 day moving average of $10.30 and a 200-day moving average of $10.71. The company has a market capitalization of $1.55 billion, a price-to-earnings ratio of -32.17 and a beta of 0.98. Indivior PLC has a 12-month low of $7.33 and a 12-month high of $18.59.

Indivior (NASDAQ:INDV - Get Free Report) last posted its earnings results on Thursday, April 24th. The company reported $0.41 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.22 by $0.19. The firm had revenue of $266.00 million for the quarter, compared to analyst estimates of $240.13 million. Indivior had a negative return on equity of 241.73% and a negative net margin of 3.96%. Sell-side analysts expect that Indivior PLC will post 1.22 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms have recently issued reports on INDV. Rodman & Renshaw started coverage on shares of Indivior in a research report on Tuesday, January 28th. They set a "buy" rating and a $16.00 price target for the company. RODMAN&RENSHAW raised Indivior to a "strong-buy" rating in a report on Tuesday, January 28th. Finally, Piper Sandler lowered their target price on Indivior from $16.00 to $13.00 and set an "overweight" rating on the stock in a report on Thursday, March 6th.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.